Pilot Study of Comprehensive Geriatric Assessment (CGA) in Allogeneic Transplant: CGA Captures a High Prevalence of Vulnerabilities in Older Transplant Recipients

Biology of Blood and Marrow Transplantation

Volumn 19, Issue 3, 2013, Pages 429-434

  Muffly, Lori S ^a   Boulukos, Melissa ^a   Swanson, Kate ^a   Kocherginsky, Masha ^a   Cerro, Paula del ^a   Schroeder, Linda ^a   Pape, Lisa ^a   Extermann, Martine ^b   Van Besien, Koen ^c   Artz, Andrew S ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Frailty; Quality of life

Indexed keywords

ALEMTUZUMAB; SERUM ALBUMIN;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; AGED; ALBUMIN BLOOD LEVEL; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; BODY MASS; CHRONIC LYMPHATIC LEUKEMIA; CHRONIC MYELOID LEUKEMIA; COMORBIDITY; COMPREHENSIVE GERIATRIC ASSESSMENT; DAILY LIFE ACTIVITY; DISABILITY; EXHAUSTION; FEMALE; FUNCTIONAL STATUS; GERIATRIC ASSESSMENT; GRAFT RECIPIENT; GRIP STRENGTH; HEALTH STATUS; HLA MATCHING; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIFE EXPECTANCY; MAJOR CLINICAL STUDY; MALE; MALNUTRITION; MENTAL FUNCTION; MENTAL HEALTH; NONHODGKIN LYMPHOMA; NUTRITIONAL STATUS; PHYSICAL ACTIVITY; PILOT STUDY; PROSPECTIVE STUDY; QUALITY OF LIFE; SELF REPORT; SHORT FORM 36; WALKING SPEED; WEIGHT REDUCTION;

ACTIVITIES OF DAILY LIVING; AGED; AGED, 80 AND OVER; FEMALE; FRAIL ELDERLY; GERIATRIC ASSESSMENT; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MENTAL HEALTH; MIDDLE AGED; NUTRITIONAL STATUS; PILOT PROJECTS; PROSPECTIVE STUDIES; RESEARCH DESIGN; SELF REPORT; TRANSPLANTATION, HOMOLOGOUS;

EID: 84873728132     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2012.11.006     Document Type: Article

References (33)

1. van Besien K., Artz A., Stock W. Unrelated donor transplantation over the age of 55: are we merely getting (b)older?. Leukemia 2005, 19:31-33.
2. Extermann M., Hurria A. Comprehensive geriatric assessment for older patients with cancer. J Clin Oncol 2007, 25:1824-1831.
3. Extermann M., Aapro M., Bernabei R., et al. Use of comprehensive geriatric assessment in older cancer patients: recommendations from the Task Force on CGA of the International Society of Geriatric Oncology (SIOG). Crit Rev Oncol Hematol 2005, 55:241-252.
4. Kanesvaran R., Li H., Koo K.N., et al. Analysis of prognostic factors of comprehensive geriatric assessment and development of a clinical scoring system in elderly Asian patients with cancer. J Clin Oncol 2011, 29:3620-3627.
5. Soubeyran P., Fonck M., Blanc-Bisson C., et al. Predictors of early death risk in older patients treated with first-line chemotherapy for cancer. J Clin Oncol 2012, 30:1829-1834.
6. Rao A.V., Hsieh F., Feussner J.R., et al. Geriatric evaluation and management units in the care of the frail elderly cancer patient. J Gerontol A Biol Sci Med Sci 2005, 60:798-803.
7. McCorkle R., Strumpf N.E., Nuamah I.F., et al. A specialized home care intervention improves survival among older post-surgical cancer patients. J Am Geriatr Soc 2000, 48:1707-1713.
8. Artz A.S. Comorbidity and beyond: pre-transplant clinical assessment. Bone Marrow Transplant 2005, 36:473-474.
9. McSweeney P.A., Niederwieser D., Shizuru J.A., et al. Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects. Blood 2001, 97:3390-3400.
10. van Besien K., Artz A., Smith S., et al. Fludarabine, melphalan, and alemtuzumab conditioning in adults with standard-risk advanced acute myeloid leukemia and myelodysplastic syndrome. J Clin Oncol 2005, 23:5728-5738.
11. van Besien K., Stock W., Rich E., et al. Phase I-II study of clofarabine-melphalan-alemtuzumab conditioning for allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 2012, 18:913-921.
12. O'Donnell P.H., Artz A.S., Undevia S.D., et al. Phase I study of dose-escalated busulfan with fludarabine and alemtuzumab as conditioning for allogeneic hematopoietic stem cell transplant: reduced clearance at high doses and occurrence of late sinusoidal obstruction syndrome/veno-occlusive disease. Leuk Lymphoma 2010, 51:2240-2249.
13. Charlson M.E., Pompei P., Ales K.L., et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987, 40:373-383.
14. Sorror M.L., Maris M.B., Storb R., et al. Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT. Blood 2005, 106:2912-2919.
15. Miller M.D., Paradis C.F., Houck P.R., et al. Rating chronic medical illness burden in geropsychiatric practice and research: application of the Cumulative Illness Rating Scale. Psychiatry Res 1992, 41:237-248.
16. Kaplan M.H., Feinstein A.R. The importance of classifying initial co-morbidity in evaluatin the outcome of diabetes mellitus. J Chronic Dis 1974, 27:387-404.
17. Fried L.P., Tangen C.M., Walston J., et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 2001, 56:M146-M156.
18. Oken M.M., Creech R.H., Tormey D.C., et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 1982, 5:649-655.
19. Lawton M.P., Brody E.M. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist 1969, 9:179-186.
20. Ware J.E., Gandek B. Overview of the SF-36 Health Survey and the International Quality of Life Assessment (IQOLA) Project. J Clin Epidemiol 1998, 51:903-912.
21. Harris T.B., Ferrucci L., Tracy R.P., et al. Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. Am J Med 1999, 106:506-512.
22. QualityMetric. SF Health Surveys. Available from:. Accessed June 30, 2012. http://www.qualitymetric.com.
23. Ware J.E. SF-36 health survey update. Spine 2000, 25:3130-3139.
24. Cawthon P.M., Marshall L.M., Michael Y., et al. Frailty in older men: prevalence, progression, and relationship with mortality. J Am Geriatr Soc 2007, 55:1216-1223.
25. Woods N.F., LaCroix A.Z., Gray S.L., et al. Frailty: emergence and consequences in women aged 65 and older in the Women's Health Initiative Observational Study. J Am Geriatr Soc 2005, 53:1321-1330.
26. Piccirillo J.F., Tierney R.M., Costas I., et al. Prognostic importance of comorbidity in a hospital-based cancer registry. JAMA 2004, 291:2441-2447.
27. Sorror M.L. Comorbidities and hematopoietic cell transplantation outcomes. Hematology Am Soc Hematol Educ Program 2010, 2010:237-247.
28. Sorror M.L., Giralt S., Sandmaier B.M., et al. Hematopoietic cell transplantation-specific comorbidity index as an outcome predictor for patients with acute myeloid leukemia in first remission: combined FHCRC and MDACC experiences. Blood 2007, 110:4606-4613.
29. Wedding U., Roehrig B., Klippstein A., et al. Comorbidity in patients with cancer: prevalence and severity measured by cumulative illness rating scale. Crit Rev Oncol Hematol 2007, 61:269-276.
30. Hurria A., Togawa K., Mohile S.G., et al. Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study. J Clin Oncol 2011, 29:3457-3465.
31. Klepin H.D., Geiger A.M., Tooze J.A., et al. The feasibility of inpatient geriatric assessment for older adults receiving induction chemotherapy for acute myelogenous leukemia. J Am Geriatr Soc 2011, 59:1837-1846.
32. Rumsfeld J.S., MaWhinney S., McCarthy M., et al. participants of the Department of Veterans Affairs Cooperative Study Group on Processes, Structures, and Outcomes of Care in Cardiac Surgery. Health-related quality of life as a predictor of mortality following coronary artery bypass graft surgery. JAMA 1999, 281:1298-1303.
33. Sloan J.A., Zhao X., Novotny P.J., et al. Relationship between deficits in overall quality of life and non-small-cell lung cancer survival. J Clin Oncol 2012, 30:1498-1504.